Skip to main content
. 2022 Mar 4;355(5):2100360. doi: 10.1002/ardp.202100360

Figure 20.

Figure 20

In silico screening to identify SARS‐CoV‐2 RdRp inhibitors from alkaloids and flavonoids. RdRp, RNA‐dependent RNA polymerase; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2